agilon health Inc (AGL) Stock Forecast & Price Target
agilon health Inc · NYSE
$91.54+3.04 (+3.44%)
15-min delayed · Sep 8, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 11 firms covering agilon health Inc, 4 rate it Buy or better, 6 sit at Hold, and 1 rate it Sell or worse, a moderate buy consensus. The target range is very wide, $35.00 to $146.00 (about 4.2x), which points to deep disagreement over how to value the company rather than near-term timing. The average target of $92.82 sits 1% above the current $91.54. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees revenue growth near -4% this year and 6% next, consensus EPS building from about $-3.37 next quarter toward $2.06 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS11 ratings
Moderate Buy
Strong Buy00%
Buy436%
Hold655%
Sell19%
Strong Sell00%
Based on 11 analysts giving stock ratings to agilon health Inc.
As of Sep, 4 of 11 firms rate AGL a Buy (6 Hold, 1 Sell), the standing distribution of every covering firm's most recent active call.
AGL EPS & revenue forecast
EPS · NEXT QUARTER
$-3.37
Range $-4.36 – $-2.30 · 11 analysts · -71% YoY
Next period, 11 analysts expect agilon health Inc to earn $-3.37 a share (range $-4.36 – $-2.30), versus $-11.50 a year earlier. Full-year consensus is $-1.50, growing to $2.06 the year after.
REVENUE · NEXT QUARTER
$1.5B
Range $1.4B – $1.5B · 11 analysts · -2% YoY
Revenue is expected to reach $1.5B (range $1.4B – $1.5B), -2.0% year-over-year. Full-year consensus is $5.8B, rising to $6.2B next year.
Top analysts covering agilon health Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on AGL.
#1
BS
Bill Sutherland
Benchmark · Rank #45
Buy
$140.00+52.9% to target
Overall win rate
45%
+ Follow
#2
Constantine Davides
JMP Securities · Rank #298
Hold
No targeton AGL
Overall win rate
35%
+ Follow
#3
Stephen Baxter
Wells Fargo
Buy
$146.00+59.5% to target
Coverage
—
+ Follow
#4
Daniel Grosslight
Citigroup
Hold
$115.00+25.6% to target
Coverage
—
+ Follow
#5
Andrew Mok
Barclays
Hold
$111.00+21.3% to target
Coverage
—
+ Follow
AGL stock forecast FAQ
What is AGL's average 12-month price target?+
The 11 analysts with a live target average $92.82 for agilon health Inc over the next 12 months, ranging from a $146.00 high to a $35.00 low.
Is AGL stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 11 analyst ratings, 4 are Buy or Strong Buy, 6 are Hold, and 1 are Sell or Strong Sell.
What are the highest and lowest price targets for AGL?+
The Street-high target is $146.00 (Wells Fargo), and the Street-low is $35.00 (Baird). The average of all 11 active targets is $92.82.
How many Wall Street analysts cover AGL?+
11 analysts have an active rating on agilon health Inc, and 11 firms carry a live 12-month price target.
Who is the most accurate analyst covering AGL?+
Among analysts who currently cover AGL, Bill Sutherland of Benchmark has the strongest overall Quantellect track record (Rank #45). Their current call is Buy with a $140.00 target.
What is agilon health Inc's projected EPS for next quarter?+
The consensus estimate is $-3.37 per share (range $-4.36 – $-2.30) across 11 analysts. Full-year EPS is projected at $-1.50, rising to $2.06 the following year.
How much revenue is agilon health Inc expected to report next quarter?+
Consensus revenue is $1.5B (range $1.4B – $1.5B). Full-year revenue is projected at $5.8B, growing to $6.2B next year.
Have analysts been upgrading or downgrading AGL lately?+
As of Sep, 4 of 11 firms rate AGL a Buy (6 Hold, 1 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their AGL calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
